Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Human insulin's gene

DNA → Patent DNA · Automatic (BLAST)

Download as Excel

Every list and the search record, one sheet each.

Query
INS · 333 lettersATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG
Set
Public patent sequences: Patent DNA, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
3,194 sequences, 1,584 publications, 1,066 families

BLAST can miss matches that an exact scan or Smith-Waterman finds.

Charts

Identity against coverage

3,194 hits by identity and query coverage. 3,194 with a date.

Has a date00101020203030404050506060707080809090100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%382382
95 to 99.9%273273
90 to 94.9%264264
80 to 89.9%1,4061,406
70 to 79.9%863863
50 to 69.9%66
Hits by query coverage
BandHas a dateAll
100%176176
95 to 99.9%510510
90 to 94.9%22
80 to 89.9%1111
70 to 79.9%193193
50 to 69.9%5656
Under 50%2,2462,246

Hits by year

1,066 families by year of first publication, 1979 to 2026.

Has a dateFamilies020406080197919831987199119951999200320072011201520192023
Show table
Families by year of first publication
YearHas a dateAll
197922
198133
198266
198311
198455
198544
198677
198744
198833
198955
199088
199233
199544
199633
199744
199866
199988
20001111
20012222
20023636
20032828
20043333
20053434
20063333
20073535
20083535
20094242
20104242
20116363
20123939
20133737
20143434
20154747
20163737
20175656
20184343
20195353
20204242
20215757
20223838
20232727
20243333
20252828
202655

Where hits align on the query

The top 20 hits on INS, a query of 333 bases: 20 cover the whole query, none differs from it.

Aligned partDiffers from the queryINS · 333 bases150100150200250300333A57719.1AR102881.1AR300598.1AX384892.1BD224077.1CQ714703.1GX863382.1DL255436.1FU371285.1FU424096.1HI201319.1HI394608.1HI394612.1HD058979.1FW369459.1FW369460.1GZ866940.1HK527381.1HK527379.1HK527380.1
Show table
The top 20 hits on INS, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atN at
A57719.11333100.0%NoneNoneNone
AR102881.11333100.0%NoneNoneNone
AR300598.11333100.0%NoneNoneNone
AX384892.11333100.0%NoneNoneNone
BD224077.11333100.0%NoneNoneNone
CQ714703.11333100.0%NoneNoneNone
GX863382.11333100.0%NoneNoneNone
DL255436.11333100.0%NoneNoneNone
FU371285.11333100.0%NoneNoneNone
FU424096.11333100.0%NoneNoneNone
HI201319.11333100.0%NoneNoneNone
HI394608.11333100.0%NoneNoneNone
HI394612.11333100.0%NoneNoneNone
HD058979.11333100.0%NoneNoneNone
FW369459.11333100.0%NoneNoneNone
FW369460.11333100.0%NoneNoneNone
GZ866940.11333100.0%NoneNoneNone
HK527381.11333100.0%NoneNoneNone
HK527379.11333100.0%NoneNoneNone
HK527380.11333100.0%NoneNoneNone

Patents 1.6K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

1,584 publications in 1,066 families match these filters.

  1. US 4431740-A1984-02-14

    DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes

    The Regents of the University of California

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 11 to 343. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    11 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 70
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    71 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 130
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   131 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 190
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   191 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 250
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   251 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 310
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   311 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 343
    

    333 of 333 identical, no gaps.

  2. WO 9632489-A11996-10-17

    GLUCOSE-INDUCIBLE RECOMBINANT VIRAL VECTOR

    INST NAT SANTE RECH MED (FR)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 11 to 343. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    11 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 70
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    71 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 130
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   131 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 190
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   191 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 250
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   251 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 310
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   311 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 343
    

    333 of 333 identical, no gaps.

  3. US 6087129-A2000-07-11

    Recombinant expression of proteins from secretory cell lines

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 23 to 355. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    23 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 82
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    83 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 142
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   143 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 202
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   203 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 262
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   263 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 322
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   323 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 355
    

    333 of 333 identical, no gaps.

  4. US 6110707-A2000-08-29

    Recombinant expression of proteins from secretory cell lines

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 23 to 355. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    23 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 82
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    83 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 142
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   143 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 202
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   203 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 262
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   263 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 322
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   323 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 355
    

    333 of 333 identical, no gaps.

  5. US 6194176-A2001-02-27

    Recombinant expression of proteins from secretory cell lines

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 23 to 355. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    23 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 82
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    83 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 142
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   143 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 202
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   203 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 262
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   263 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 322
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   323 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 355
    

    333 of 333 identical, no gaps.

  6. WO 0168828-A22001-09-20

    Compositions and methods for regulated protein expression in gut

    Engene, Inc. (CA)

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  7. US 6309878-A2001-10-30

    Glucose-inducible recombinant viral vector

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 11 to 343. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    11 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 70
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    71 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 130
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   131 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 190
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   191 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 250
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   251 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 310
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   311 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 343
    

    333 of 333 identical, no gaps.

  8. WO 0212327-A22002-02-14

    Compositions and methods for the therapy and diagnosis of pancreatic cancer

    CORIXA CORPORATION (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 65 to 397. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    65 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 124
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   125 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 184
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   185 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 244
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   245 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 304
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   305 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 364
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   365 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 397
    

    333 of 333 identical, no gaps.

  9. WO 0228408-A22002-04-11

    Compositions and methods for the transport of biologically active agents across cellular barriers

    ARIZEKE PHARMACEUTICALS, INC. (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  10. JP 2002524087-A2002-08-06

    Method for studying protein interactions in vivo

    LOMA LINDA UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
    

    333 of 333 identical, no gaps.

  11. WO 02068579-A22002-09-06

    Kits, such as nucleic acid arrays, comprising a majority of humanexons or transcripts, for detecting expression and other uses thereof

    PE Corporation (NY) (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  12. US 6537806-A2003-03-25

    Compositions and methods for treating diabetes

    University of Washington

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  13. JP 2005521635-A2005-07-21

    REMODELING AND GLYCOCONJUGATION OF PEPTIDES

    Neose Technologies Inc

    Query Match 100.0%Identity 100.0%Family of 14

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 14

    Grouped by a shared priority claim, US 60/334233.

  14. WO 2005084697-A2005-09-15

    THE REGULATORS OF EXPRESSION OF ADIPONECTIN RECEPTORS

    TAKASHI KADOWAKI,TOSHIMASA YAMAUCHI

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  15. Novel herpes simplex viruses

    Crusade Laboratories Limited (GB)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  16. JP 2006503588-A2006-02-02

    MODIFIED TRANSFERRIN FUSION PROTEINS

    BIOREXIS PHARMACEUTICAL CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  17. Expression of Mammalian Proteins in Pseudomonas fluorescens

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
    

    333 of 333 identical, no gaps.

  18. JP 2006522738-A2006-10-05

    ERYTHROPOIETIN: REMODELING AND GLYCOCONJUGATION OF ERYTHROPOIETIN

    Neose Technologies Inc,Shawn DeFrees,David Zopf,Robert Bayer,David Hakes, Xi Chen,Caryne Bowe

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  19. US 7125843-A2006-10-24

    Glycoconjugates including more than one peptide

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  20. EP 1716256-A22006-11-02

    Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

    COMPUGEN LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 311 to 643. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   311 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 370
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   371 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 430
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   431 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 490
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   491 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 550
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   551 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 610
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   611 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 643
    

    333 of 333 identical, no gaps.

  21. US 7157277-A2007-01-02

    Factor VIII remodeling and glycoconjugation of Factor VIII

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  22. US 7173003-A2007-02-06

    Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  23. US 7179617-A2007-02-20

    Factor IX: remolding and glycoconjugation of Factor IX

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  24. US 7226903-A2007-06-05

    Interferon beta: remodeling and glycoconjugation of interferon beta

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  25. JP 2007519402-A2007-07-19

    Expression of Mammalian Proteins in Pseudomonas fluorescens

    Dow Global Technologies Inc

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
    

    333 of 333 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 60/537148.

  26. US 7265084-A2007-09-04

    Glycopegylation methods and proteins/peptides produced by the methods

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  27. US 7265085-A2007-09-04

    Glycoconjugation methods and proteins/peptides produced by the methods

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  28. JP 2007525941-A2007-09-13

    GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS

    Neose Technologies Inc,Shawn DeFrees,David Zopf,Robert Bayer,David Hakes, Xi Chen,Caryne Bowe

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  29. US 7297511-A2007-11-20

    Interferon alpha: remodeling and glycoconjugation of interferon alpha

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  30. US 7341869-A2008-03-11

    Compositions and methods for treating diabetes

    The University of Washington

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  31. WO 2008050870-A2008-05-02

    Organ-specific Genes, Method for Identifying Same and Use Thereof

    TAKEDA PHARMACEUTICAL COMPANY LIMITED

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 36 to 368. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    36 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 95
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    96 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 155
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   156 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 215
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   216 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 275
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   276 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 335
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   336 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 368
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. JP 2008518610-A2008-06-05

    Transcriptome Microarray Technology and Methods of Using the Same

    Arradx Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 51 to 383. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    51 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 110
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   111 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 170
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   171 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 230
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   231 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 290
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   291 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 350
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   351 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 383
    

    333 of 333 identical, no gaps.

  33. US 7399613-A2008-07-15

    Sialic acid nucleotide sugars

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  34. US 7416858-A2008-08-26

    Pharmaceutical compositions of glycoconjugates

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  35. US 7439043-A2008-10-21

    Galactosyl nucleotide sugars

    Neose Technologies, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  36. EP 2042189-A12009-04-01

    Use of proinsulin for the preparation of a neuroprotective pharmaceutical composition, therapeutic composition containing it and applications thereof

    CONSEJO SUPERIOR INVESTIGACION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 64 to 396. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    64 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 123
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   124 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 183
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 243
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   244 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 303
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   304 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 363
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   364 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 396
    

    333 of 333 identical, no gaps.

  37. EP 2042196-A22009-04-01

    Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)

    Neose Technologies, Inc. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  38. EP 2097540-A22009-09-09

    Genemap of the human genes associated with crohn's disease

    GENIZON BIOSCIENCES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 96 to 428. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    96 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 155
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   156 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 215
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   216 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 275
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   276 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 335
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   336 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 395
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   396 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 428
    

    333 of 333 identical, no gaps.

  39. US 7696163-B22010-04-13

    Erythropoietin: remodeling and glycoconjugation of erythropoietin

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  40. JP 2010124782-A2010-06-10

    Method of preparing protein using nematodes

    Chubu University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 1410 to 1742. Positions start at 1 and include both ends.

    Query    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1410 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 1469
    
    Query   61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1470 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 1529
    
    Query  121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1530 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 1589
    
    Query  181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1590 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 1649
    
    Query  241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1650 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 1709
    
    Query  301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
               |||||||||||||||||||||||||||||||||
    Hit   1710 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 1742
    

    333 of 333 identical, no gaps.

  41. Biomarkers for insulin sensitizer drug response

    IKFE GmbH (DE)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392
    

    333 of 333 identical, no gaps.

  42. US 7795210-B22010-09-14

    Protein remodeling methods and proteins/peptides produced by the methods

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  43. US 7842459-B22010-11-30

    Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

    Compugen Ltd.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 311 to 643. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   311 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 370
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   371 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 430
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   431 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 490
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   491 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 550
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   551 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 610
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   611 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 643
    

    333 of 333 identical, no gaps.

  44. EP 2265641-A12010-12-29

    BIOMARKERS

    OTAGO INNOVATION LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392
    

    333 of 333 identical, no gaps.

  45. EP 2279754-A22011-02-02

    Remodelling and glycoconjugation of human growth hormone (hGH)

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  46. EP 2279755-A22011-02-02

    Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF)

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  47. EP 2292271-A22011-03-09

    Remodelling and glycoconjugation of an antibody

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  48. EP 2298354-A22011-03-23

    Remodelling and glycoconjugation of interferon-beta

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  49. EP 2305311-A22011-04-06

    Glycoconjugation of peptides

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.

  50. EP 2305312-A22011-04-06

    Remodelling and glycoconjugation of follicle-stimulating hormone (FSH)

    BIOGENERIX AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104
    
    Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164
    
    Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224
    
    Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284
    
    Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344
    
    Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||||||||||||||
    Hit   345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377
    

    333 of 333 identical, no gaps.